The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
Abstract
Patients with ulcerative colitis and Crohn's disease are at increased risk for developing colorectal cancer. To date, no known genetic basis has been identified to explain colorectal cancer predisposition in these inflammatory bowel diseases. Instead, it is assumed that chronic inflammation is what causes cancer. This is supported by the fact that colon cancer risk increases with longer duration of colitis, greater anatomic extent of colitis, the concomitant presence of other inflammatory manifestations such as primary sclerosing cholangitis, and the fact that certain drugs used to treat inflammation, such as 5-aminosalicylates and steroids, may prevent the development of colorectal cancer. The major carcinogenic pathways that lead to sporadic colorectal cancer, namely chromosomal instability, microsatellite instability, and hypermethylation, also occur in colitis-associated colorectal cancers. Unlike normal colonic mucosa, however, inflamed colonic mucosa demonstrates abnormalities in these molecular pathways even before any histological evidence of dysplasia or cancer. Whereas the reasons for this are unknown, oxidative stress likely plays a role. Reactive oxygen and nitrogen species produced by inflammatory cells can interact with key genes involved in carcinogenic pathways such as p53, DNA mismatch repair genes, and even DNA base excision-repair genes. Other factors such as NF-κB and cyclooxygenases may also contribute. Administering agents that cause colitis in healthy rodents or genetically engineered cancer-prone mice accelerates the development of colorectal cancer. Mice genetically prone to inflammatory bowel disease also develop colorectal cancer especially in the presence of bacterial colonization. These observations offer compelling support for the role of inflammation in colon carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Marnett, L. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.361 · Cited by 1,883
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 2×
“Indeed, IBD is considered one of the main “oxyradical overload” diseases whereby chronic inflammation, be it inherited or acquired, results in a cancer-prone phenotype (44).”
BackgroundTherapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Mutations in the APC tumour suppressor gene cause chromosomal instability
Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C., van Es, J. H., Breukel, C., Wiegant, J., Giles, R. H., et al. (2001) · Nature Cell Biology · doi:10.1038/35070129 · Cited by 723
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin
Hermiston, M. L., & Gordon, J. I. (1995) · Science · doi:10.1126/science.270.5239.1203 · Cited by 662
Accelerated age-related CpG island methylation in ulcerative colitis.
Issa, J. J., Ahuja, N., Toyota, M., Bronner, M. P., & Brentnall, T. A. (2001) · PubMed · Cited by 627
Colorectal cancer prevention in ulcerative colitis: a case‐control study
Eaden, Abrams, Ekbom, Jackson, & Mayberry (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00698.x · Cited by 577
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
Rubin, C. E., Haggitt, R. C., Burmer, G. C., Brentnall, T. A., Stevens, A. C., Levine, D. S., Dean, P. J., Kimmey, M., Perera, D. R., & Rabinovitch, P. S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91185-7 · Cited by 568
C-Reactive Protein and the Risk of Incident Colorectal Cancer
Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 533
Emerging concepts in colorectal neoplasia
Jass, J. R., Whitehall, V. L. J., Young, J., & Leggett, B. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35392 · Cited by 495
Hussain, S. P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Bennett, W. P., Shields, P. G., Ham, A. L., Swenberg, J. A., Marrogi, A. J., et al. (2000) · PubMed · Cited by 482
Seril, D. N. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.353 · Cited by 467
Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
Brentnall, T. A., Crispin, D. A., Rabinovitch, P. S., Haggitt, R. C., Rubin, C. E., Stevens, A. C., & Burmer, G. C. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90161-9 · Cited by 432
Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
Dubuquoy, L., Jansson, E. Å., Deeb, S., Rakotobe, S., Karoui, M., Colombel, J.-F., Auwerx, J., Pettersson, S., & Desreumaux, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00271-3 · Cited by 424
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
Itzkowitz, S. H., & Harpaz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.025 · Cited by 423
Self-citationChanges in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Santini, V., Kantarjian, H. M., & Issa, J.-P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00011 · Cited by 414
Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice
Rudolph, U., Finegold, M. J., Rich, S. S., Harriman, G. R., Srinivasan, Y., Brabet, P., Boulay, G., Bradley, A., & Birnbaumer, L. (1995) · Nature Genetics · doi:10.1038/ng0695-143 · Cited by 410
Rachmilewitz, D., Stamler, J. S., Bachwich, D., Karmeli, F., Ackerman, Z., & Podolsky, D. K. (1995) · Gut · doi:10.1136/gut.36.5.718 · Cited by 365
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice
Balish, E., & Warner, T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61172-8 · Cited by 353
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
McKenzie, S. J., Baker, M. S., Buffinton, G. D., & Doe, W. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118757 · Cited by 349
Chromosomal instability in ulcerative colitis is related to telomere shortening
O'Sullivan, J. N., Bronner, M. P., Brentnall, T. A., Finley, J. C., Shen, W.-T., Emerson, S., Emond, M. J., Gollahon, K. A., Moskovitz, A. H., Crispin, D. A., et al. (2002) · Nature Genetics · doi:10.1038/ng989 · Cited by 346
Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
Pinczowski, D., Ekbom, A., Baron, J., Yuen, J., & Adami, H.-O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90068-x · Cited by 337
Bacteria-Induced Intestinal Cancer in Mice with DisruptedGpx1andGpx2Genes
Chu, F.-F., Esworthy, R. S., Chu, P. G., Longmate, J. A., Huycke, M. M., Wilczynski, S., & Doroshow, J. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2272 · Cited by 306
CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice
Erdman, S. E., Poutahidis, T., Tomczak, M., Rogers, A. B., Cormier, K., Plank, B., Horwitz, B. H., & Fox, J. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63863-1 · Cited by 303
Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice
O'Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O'Sullivan, G., Shanahan, F., & Collins, J. K. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01027.x · Cited by 298
Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of a p53 allele
Burmer, G. C., Rabinovitch, P. S., Haggitt, R. C., Crispin, D. A., Brentnall, T. A., Kolli, V. R., Stevens, A. C., & Rubin, C. E. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91184-6 · Cited by 280
Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.
Brentnall, T. A., Crispin, D. A., Bronner, M. P., Cherian, S. P., Hueffed, M., Rabinovitch, P. S., Rubin, C. E., Haggitt, R. C., & Boland, C. R. (1996) · PubMed · Cited by 280
Oxidative stress inactivates the human DNA mismatch repair system
Chang, C. L., Marra, G., Chauhan, D. P., Ha, H. T., Chang, D. K., Ricciardiello, L., Randolph, A., Carethers, J. M., & Boland, C. R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00422.2001 · Cited by 262
Peroxynitrite-induced rat colitis—A new model of colonic inflammation
Rachmilewitz, D., Stamler, J. S., Karmeli, F., Mullins, M. E., Singel, D. J., Loscalzo, J., Xavier, R. J., & Podolsky, D. K. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91063-n · Cited by 259
Kimura, H., Hokari, R., Miura, S., Shigematsu, T., Hirokawa, M., Akiba, Y., Kurose, I., Higuchi, H., Fujimori, H., Tsuzuki, Y., et al. (1998) · Gut · doi:10.1136/gut.42.2.180 · Cited by 250
Hsieh, C. ‐., Klump, B., Holzmann, K., Borchard, F., Gregor, M., & Porschen, R. (1998) · PubMed · Cited by 241
p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions
Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B. D., Hontanosas, M., Newkirk, C., & Meltzer, S. J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90639-t · Cited by 236
Fleisher, A. S., Esteller, M., Harpaz, N., Leytin, A., Rashid, A., Xu, Y., Liang, J., Stine, O. C., Yin, J., Zou, T., et al. (2000) · PubMed · Cited by 231
Engle, S. J., Hoying, J. B., Boivin, G. P., Ormsby, I., Gartside, P. S., & Doetschman, T. C. (1999) · PubMed · Cited by 216
Cooper, H. S., Murthy, S., Kido, K., Yoshitake, H., & Flanigan, A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.757 · Cited by 213
Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M. F., Rogers, A. B., Horwitz, B. H., & Fox, J. G. (2003) · PubMed · Cited by 210
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.
Engle, S. J., Ormsby, I., Pawlowski, S. A., Boivin, G. P., Croft, J., Balish, E., & Doetschman, T. C. (2002) · PubMed · Cited by 199
Hofseth, L. J., Khan, M. A., Ambrose, M., Nikolayeva, O., Xu-Welliver, M., Kartalou, M., Hussain, S. P., Roth, R. B., Zhou, X., Mechanic, L. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19757 · Cited by 198
Willenbucher, R. F., Aust, D. E., Chang, C. G., Zelman, S. J., Ferrell, L. D., Moore, D. H., & Waldman, F. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65438-7 · Cited by 179
Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL–10−/− mice
Shattuck-Brandt, R. L., Varilek, G. W., Radhika, A., Yang, F., Washington, M. K., & DuBois, R. N. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70216-2 · Cited by 179
Tarmin, L., Yin, J., Harpaz, N., Kozam, M., Noordzij, J. G., Antonio, L. B., Jiang, H., Chan, O., Cymes, K., & Meltzer, S. J. (1995) · PubMed · Cited by 178
Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis.
Rabinovitch, P. S., Dziadon, S. M., Brentnall, T. A., Emond, M. J., Crispin, D. A., Haggitt, R. C., & Bronner, M. P. (1999) · PubMed · Cited by 174
The Role of Cyclooxygenase 2 in Ulcerative Colitis-Associated Neoplasia
Agoff, S. N., Brentnall, T. A., Crispin, D. A., Taylor, S. L., Raaka, S., Haggitt, R. C., Reed, M. W., Afonina, I. A., Rabinovitch, P. S., Stevens, A. C., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64587-7 · Cited by 170
KADO, S., Uchida, K., Funabashi, H., Iwata, S., Nagata, Y., Ando, M., Onoue, M., Matsuoka, Y., Ohwaki, M., & Morotomi, M. (2001) · PubMed · Cited by 150
Niho, N., Takahashi, M., Kitamura, T., Shoji, Y., Itoh, M., Noda, T., Sügimura, T., & Wakabayashi, K. (2003) · PubMed · Cited by 148
Is inducible nitric oxide synthase a target for chemoprevention?
Crowell, J. A., Steele, V. E., Sigman, C. C., & Fay, J. R. (2003) · PubMed · Cited by 148
Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
Ahn, B., & Ohshima, H. (2001) · PubMed · Cited by 145
Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias
Redston, M. S., Papadopoulos, N., Caldas, C., Kinzler, K. W., & Kern, S. E. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90064-0 · Cited by 139
The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas
Aust, D. E., Terdiman, J. P., Willenbucher, R. F., Chang, C. G., Molinaro‐Clark, A., Baretton, G. B., Loehrs, U., & Waldman, F. M. (2002) · Cancer · doi:10.1002/cncr.10334 · Cited by 139
Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
Sato, F., Harpaz, N., Shibata, D., Xu, Y. H., Yin, J., Mori, Y., Zou, T., Wang, S., Desai, K., Leytin, A., et al. (2002) · PubMed · Cited by 136
Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.
Ricciardiello, L., Baglioni, M., Giovannini, C., Pariali, M., Cenacchi, G., Ripalti, A., Landini, M. P., Sawa, H., Nagashima, K., Frisque, R. J., et al. (2003) · PubMed · Cited by 121
Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis
Mathy, C., Schneider, K., Chen, Y., Varma, M. G., Terdiman, J. P., & Mahadevan, U. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200311000-00002 · Cited by 114
Renata D'Incà, Cardin, R., Benazzato, L., Angriman, I., Martines, D., & Sturniolo, G. C. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200401000-00003 · Cited by 112
Animal models of inflammatory bowel disease
Hibi∥, T., Ogata, H., & Sakuraba, A. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200060 · Cited by 111
Dysplasia and carcinoma development in a repeated dextran sulfate sodium‐induced colitis model
Okayasu, I., Yamada, M., Mikami, T., Yoshida, T., Kanno, J., & Ohkusa, T. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02853.x · Cited by 110
Cooper, H. S., Everley, L., Chang, W.-C. J., Pfeiffer, G. R., Lee, B., Murthy, S., & Clapper, M. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.29609 · Cited by 107
Oxidative stress increases frameshift mutations in human colorectal cancer cells.
Gasché, C., Chang, C. L., Rhees, J., Goel, A., & Boland, C. R. (2001) · PubMed · Cited by 106
Paradoxical roles of different nitric oxide synthase isoforms in colonic injury
Beck, P. L., Xavier, R. J., Wong, J., Ezedi, I., Mashimo, H. L., Mizoguchi, A., Mizoguchi, E., Bhan, A. K., & Podolsky, D. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00309.2003 · Cited by 106
Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
Šturlan, S., Oberhuber, G., Beinhauer, B. G., Tichy, B., Kappel, S., Wang, J., & Rogy, M. A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.665 · Cited by 99
Steele, V. E., Hawk, E. T., Viner, J. L., & Lubet, R. A. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00329-9 · Cited by 92
Seril, D. N., Liao, J., Ho, K.-L. K., Yang, C. S., & Yang, G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.993 · Cited by 91
Brentnall, T. A., Rubin, C. E., Crispin, D. A., Stevens, A. C., Batchelor, R. H., Haggitt, R. C., Bronner, M. P., Evans, J. P., McCahill, L. E., Bilir, N., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90280-5 · Cited by 89
Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis
Hokari, R., Kato, S., Matsuzaki, K., Kuroki, M., Iwai, A., Kawaguchi, A., Nagao, S., Miyahara, T., Itoh, K., Sekizuka, E., et al. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00565-2 · Cited by 82
Chen, R., Rabinovitch, P. S., Crispin, D. A., Emond, M. J., Koprowicz, K. M., Bronner, M. P., & Brentnall, T. A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63860-6 · Cited by 73
Arai, N., Mitomi, H., Ohtani, Y., et al. (1999) · PubMed · Cited by 69
Hisamatsu, T., Watanabe, M., Ogata, H., Ezaki, T., Hozawa, S., Ishii, H., Kanai∥, T., & Hibi∥, T. (1999) · PubMed · Cited by 57
Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
Kohonen‐Corish, M. R. J., Daniel, J. J., Riele, H. T., Buffinton, G. D., & Dahlstrom, J. E. (2002) · PubMed · Cited by 54
Ritland, S., Leighton, J. A., Hirsch, R. E., Morrow, J. D., Weaver, A. L., & Gendler, S. J. (1999) · PubMed · Cited by 43
Sohn, K., Shah, S. A., Reid, S., Choi, M., Carrier, J. C., Comiskey, M., Terhorst, C., & Kim, Y. (2001) · PubMed · Cited by 38
Bull, A. W. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1121-troppr · Cited by 37
Hegazi, R. A. F., Mady, H. H., Melhem, M. F., Sepulveda, A. R., Mohi, M., & Kandil, H. M. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00003 · Cited by 34
Noffsinger, A. E., Belli, J., Fogt, F., FISCHER, J., GOLDMAN, H., & Fenoglio‐Preiser, C. M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90293-9 · Cited by 33
New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity
Gupta, R. A., DuBois, R. N., & Wallace, M. C. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0353 · Cited by 12
Cited by
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Metadata
- Authors
- Itzkowitz, S. H., & Yio, X.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2004-07
- Volume
- 287
- Issue
- 1
- Pages
- G7-G17
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2147923982
- Cited by
- 1,274
- References
- 82
- FWCI
- 25.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.